Invasive group A streptococcal disease surveillance in Canada, 2021-2022.
Canada
Streptococcus pyogenes
antimicrobial resistance
emm
group A Streptococcus
iGAS
surveillance
Journal
Canada communicable disease report = Releve des maladies transmissibles au Canada
ISSN: 1188-4169
Titre abrégé: Can Commun Dis Rep
Pays: Canada
ID NLM: 9303729
Informations de publication
Date de publication:
24 May 2024
24 May 2024
Historique:
medline:
5
6
2024
pubmed:
5
6
2024
entrez:
5
6
2024
Statut:
epublish
Résumé
Invasive group A streptococcal (iGAS, The Public Health Agency of Canada's National Microbiology Laboratory collaborates with provincial and territorial public health laboratories to conduct national surveillance of invasive Overall, the incidence of iGAS disease in Canada was 5.56 cases per 100,000 population in 2021, decreasing from the peak of 8.6 cases per 100,000 population in 2018. A total of 2,630 iGAS isolates were collected during 2022, representing an increase from 2021 (n=2,179). In particular, there was a large increase in isolates collected from October to December 2022. The most predominant The increase of iGAS isolates collected in Canada is an important public health concern. Continued surveillance of iGAS is critical to monitor expanding
Sections du résumé
Background
UNASSIGNED
Invasive group A streptococcal (iGAS,
Methods
UNASSIGNED
The Public Health Agency of Canada's National Microbiology Laboratory collaborates with provincial and territorial public health laboratories to conduct national surveillance of invasive
Results
UNASSIGNED
Overall, the incidence of iGAS disease in Canada was 5.56 cases per 100,000 population in 2021, decreasing from the peak of 8.6 cases per 100,000 population in 2018. A total of 2,630 iGAS isolates were collected during 2022, representing an increase from 2021 (n=2,179). In particular, there was a large increase in isolates collected from October to December 2022. The most predominant
Conclusion
UNASSIGNED
The increase of iGAS isolates collected in Canada is an important public health concern. Continued surveillance of iGAS is critical to monitor expanding
Identifiants
pubmed: 38835501
doi: 10.14745/ccdr.v50i05a03
pii: 500503
pmc: PMC11149783
doi:
Types de publication
Journal Article
Langues
eng
Pagination
135-143Déclaration de conflit d'intérêts
Competing interests None.